Product division
Impurities & Reference Standards
Pharmacopoeial and non-pharmacopoeial impurities, metabolites, nitrosamines and working standards with characterisation data for QC and regulatory work.
27,990products
6sub-categories
2,746in stock
COA + SDSwith every lot
API Impurities 14,098Pharmacopeial Impurities (EP / USP / BP) 4,399Nitrosamine Impurities 631Stable Isotope Labelled Standards (Deuterated, 13C, 15N) 1,504Metabolites & Degradation Products 3,922API Reference Standards 3,436
1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole
- CAS
- 127000-90-2
- Formula
- C12H11F2N3O
- MW
- 251.23 g/mol
VQ-025497
1-(((2R,3S)-2-(2,5-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole
- CAS
- 241479-73-2
- Formula
- C12H11F2N3O
- MW
- 251.23 g/mol
VQ-048151
1-(((R)-3-(3-Fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methoxy)-3-hydroxypropan-2-yl dihydrogen phosphate
- CAS
- 1239662-42-0
- Formula
- C20H22FN6O8P
- MW
- 524.4 g/mol
VQ-034073
1-((1,3-Dichloropropan-2-yl)oxy)-3-(isopropylamino)propan-2-ol
- CAS
- 3048706-15-3
- Formula
- C9H19Cl2NO2
- MW
- 244.16 g/mol
VQ-027671
1-((1r,4r)-4-(2-(4-(2,3-Dichloro-4-hydroxyphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-methylurea
- CAS
- 1084891-94-0
- Formula
- C20H30Cl2N4O2
- MW
- 429.39 g/mol
VQ-044057
1-((1r,4r)-4-(2-(4-(2,3-Dichloro-4-hydroxyphenyl)piperazin-1-yl)ethyl)cyclohexyl)urea
- CAS
- 1084891-93-9
- Formula
- C19H28Cl2N4O2
- MW
- 415.36 g/mol
VQ-044058
1-((1S,2S)-1-Cyano-2-methylcyclopropyl)-5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide
- CAS
- 2212021-81-1
- Formula
- C28H31N3O2
- MW
- 441.6 g/mol
VQ-049332
1-((2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole
- CAS
- 124627-86-7
- Formula
- C12H11F2N3O
- MW
- 251.23 g/mol
VQ-044886
1-((2-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine
- CAS
- 713071-37-5
- Formula
- C25H27ClN2
- MW
- 390.9 g/mol
VQ-031754
1-((2-Chlorophenyl)diphenylmethyl)-2-methyl-1H-imidazole
- CAS
- 98751-53-2
- Formula
- C23H19ClN2
- MW
- 358.9 g/mol
VQ-022245
1-((2-Fluorophenyl)carbamoyl)cyclopropane-1-carboxylic Acid
- CAS
- 918642-61-2
- Formula
- C11H10FNO3
- MW
- 223.2 g/mol
VQ-024722
1-((2'-Cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic Acid
- CAS
- 632322-61-3
- Formula
- C24H19N3O3
- MW
- 397.4 g/mol
VQ-034955
1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one
- CAS
- 13491-41-3
- Formula
- C9H13N3O6
- MW
- 259.22 g/mol
VQ-026753
1-((2R,3S)-3-(4-(4-Cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-(((methylglycyl)oxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium Iodide Hydrochloride
- CAS
- 2169911-48-0
- Formula
- C35H36ClF2IN8O5S
- MW
- 881.1 g/mol
VQ-048707
1-((2R,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
- CAS
- 1792181-98-6
- Formula
- C15H19N5O
- MW
- 285.34 g/mol
VQ-033578
1-((2S,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
- CAS
- 2041584-99-8
- Formula
- C10H13FN2O5
- MW
- 260.22 g/mol
VQ-028069
1-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
- CAS
- 110508-94-6
- Formula
- C10H14N2O6
- MW
- 258.23 g/mol
VQ-044144
1-((2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxy-1H-imidazole-4-carboxamide
- CAS
- 126077-59-6
- Formula
- C9H13N3O6
- MW
- 259.22 g/mol
VQ-038468
1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one
- CAS
- 402725-23-9
- Formula
- C9H13N3O6
- MW
- 259.22 g/mol
VQ-031972
1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
- CAS
- 26879-47-0
- Formula
- C10H14N2O6
- MW
- 258.23 g/mol
VQ-044145
Need a price, a spec or a custom compound?
Send us your list — product names or CAS numbers, grade, quantity and destination. Our team replies with a formal quotation, COA and lead time.